Erratum: Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature

Mary K Samplaski; Warren Heston; Paul Elson; Cristina Magi-Galluzzi; Donna E Hansel

doi:10.1038/modpathol.2011.131

Erratum: Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature

Modern Pathology ◽

10.1038/modpathol.2011.131 ◽

2011 ◽

Vol 24 (11) ◽

pp. 1531-1531

Author(s):

Mary K Samplaski ◽

Warren Heston ◽

Paul Elson ◽

Cristina Magi-Galluzzi ◽

Donna E Hansel

Keyword(s):

Bladder Cancer ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Cancer Subtypes ◽

Tumor Neovasculature ◽

Folate Hydrolase

Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature

Modern Pathology ◽

10.1038/modpathol.2011.112 ◽

2011 ◽

Vol 24 (11) ◽

pp. 1521-1529 ◽

Cited By ~ 34

Author(s):

Mary K Samplaski ◽

Warren Heston ◽

Paul Elson ◽

Cristina Magi-Galluzzi ◽

Donna E Hansel

Keyword(s):

Bladder Cancer ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Cancer Subtypes ◽

Tumor Neovasculature ◽

Folate Hydrolase

EDITORIAL: DO WE HAVE A PROSTATE SPECIFIC ANTIGEN FOR BLADDER CANCER?

The Journal of Urology ◽

10.1016/s0022-5347(01)61920-7 ◽

1999 ◽

Vol 161 (2) ◽

pp. 447-448 ◽

Cited By ~ 23

Author(s):

Mark S. Soloway

Keyword(s):

Bladder Cancer ◽

Prostate Specific Antigen ◽

Specific Antigen

2054 CHARACTERISTICS OF PROSTATE CANCERS FOUND IN SPECIMENS REMOVED BY RADICAL CYSTOPROSTATECTOMY FOR BLADDER CANCER AND THEIR RELATIONSHIP WITH SERUM PROSTATE-SPECIFIC ANTIGEN LEVEL

The Journal of Urology ◽

10.1016/j.juro.2010.02.2101 ◽

2010 ◽

Vol 183 (4S) ◽

Author(s):

Tohru Nakagawa ◽

Yae Kanai ◽

Motokiyo Komiyama ◽

Hiroyuki Fujimoto ◽

Tadao Kakizoe

Keyword(s):

Bladder Cancer ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Prostate Specific Antigen Level ◽

Antigen Level ◽

Serum Prostate Specific Antigen ◽

Radical Cystoprostatectomy ◽

Prostate Cancers

Characteristics of prostate cancers found in specimens removed by radical cystoprostatectomy for bladder cancer and their relationship with serum prostate-specific antigen level

Cancer Science ◽

10.1111/j.1349-7006.2009.01267.x ◽

2009 ◽

Vol 100 (10) ◽

pp. 1880-1884 ◽

Cited By ~ 13

Author(s):

Tohru Nakagawa ◽

Yae Kanai ◽

Motokiyo Komiyama ◽

Hiroyuki Fujimoto ◽

Tadao Kakizoe

Keyword(s):

Bladder Cancer ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Prostate Specific Antigen Level ◽

Antigen Level ◽

Serum Prostate Specific Antigen ◽

Radical Cystoprostatectomy ◽

Prostate Cancers

Is Prostate-Specific Antigen Surveillance Necessary in Men with Benign Prostate Pathology following Radical Cystoprostatectomy for Bladder Cancer?

Urologia Internationalis ◽

10.1159/000321693 ◽

2010 ◽

Vol 85 (4) ◽

pp. 466-469 ◽

Cited By ~ 2

Author(s):

Trinity J. Bivalacqua ◽

Stacy Loeb ◽

Phillip M. Pierorazio ◽

Mark P. Schoenberg ◽

Alan W. Partin ◽

...

Keyword(s):

Bladder Cancer ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Radical Cystoprostatectomy ◽

Benign Prostate

Effect of the Synthetic Retinoid Fenretinide on Circulating Free Prostate-Specific Antigen, Insulin-Like Growth Factor-I, and Insulin-Like Growth Factor Binding Protein-3 Levels in Men with Superficial Bladder Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-04-1549 ◽

2005 ◽

Vol 11 (5) ◽

pp. 2083-2088 ◽

Cited By ~ 3

Author(s):

Davide Serrano ◽

Laura Baglietto ◽

Harriet Johansson ◽

Frederique Mariette ◽

Rosalba Torrisi ◽

...

Keyword(s):

Bladder Cancer ◽

Growth Factor ◽

Prostate Specific Antigen ◽

Superficial Bladder Cancer ◽

Binding Protein ◽

Specific Antigen ◽

Insulin Like Growth Factor ◽

Factor Binding ◽

Factor I ◽

Synthetic Retinoid

Are prostate biopsies mandatory in patients with prostate‐specific antigen increase during intravesical immuno‐ or chemotherapy for superficial bladder cancer?

The Prostate ◽

10.1002/pros.20790 ◽

2008 ◽

Vol 68 (11) ◽

pp. 1241-1247 ◽

Cited By ~ 10

Author(s):

Paolo Beltrami ◽

Lorenzo Ruggera ◽

Lucia Cazzoletti ◽

Dionisio Schiavone ◽

Filiberto Zattoni

Keyword(s):

Bladder Cancer ◽

Prostate Specific Antigen ◽

Superficial Bladder Cancer ◽

Specific Antigen ◽

Prostate Biopsies

Role of Multiparametric Magnetic Resonance Imaging Prostate Specific Antigen Density and PI-RADS™ Score in Predicting Up Staging in Men on Active Surveillance

Urology Practice ◽

10.1016/j.urpr.2018.05.007 ◽

2019 ◽

Vol 6 (2) ◽

pp. 117-122 ◽

Cited By ~ 1

Author(s):

Michelle Van Kuiken ◽

Robert H. Blackwell ◽

Bryan Bisanz ◽

Cara Joyce ◽

Joseph Yacoub ◽

...

Keyword(s):

Magnetic Resonance Imaging ◽

Magnetic Resonance ◽

Prostate Specific Antigen ◽

Active Surveillance ◽

Specific Antigen ◽

Resonance Imaging ◽

Multiparametric Magnetic Resonance Imaging ◽

Prostate Specific Antigen Density

1721: The Observed Correlation between Testosterone Levels and Prostate Specific Antigen Values in a Large Screening Population

The Journal of Urology ◽

10.1016/s0022-5347(18)31909-8 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 573-573

Author(s):

E. David Crawford ◽

Colin O'Donnell ◽

Al B. Barqawi

Keyword(s):

Prostate Specific Antigen ◽

Specific Antigen ◽

Testosterone Levels ◽

Screening Population

197: Prostate Cancer Screening Strategies with Rescreening Interval Determined by Individual Baseline Prostate-Specific Antigen Values are Cost-Effective

The Journal of Urology ◽

10.1016/s0022-5347(18)30462-2 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 66-66

Author(s):

Takashi Kobayashi ◽

Rei Goto ◽

Kazuto Ito ◽

Osamu Ogawa

Keyword(s):

Prostate Cancer ◽

Cancer Screening ◽

Prostate Specific Antigen ◽

Prostate Cancer Screening ◽

Specific Antigen ◽

Cost Effective ◽

Screening Strategies